Literature DB >> 9949272

Effective intra-arterial chemotherapy for acinar cell carcinoma of the pancreas.

T Ukei1, K Okagawa, Y Uemura, K Miyauchi, T Kaneko, S Mizunoya, M Monden.   

Abstract

A 41-year-old man with a huge pancreatic tumor (acinar cell carcinoma) was treated by intra-arterial infusion chemotherapy with 5-fluorouracil (5-FU), mitomycin C (MMC) and cisplatin (CDDP). The tumor was significantly reduced, and he underwent a pancreaticoduodenectomy with complete excision of the tumor. Unfortunately multiple metastatic liver tumors were noted 5 months after resection. These tumors could also be markedly reduced by intra-arterial chemotherapy and the survival period was prolonged to 18 months. He suddenly died of sepsis but not from the pancreatic carcinoma. This case shows that intra-arterial infusion chemotherapy with 5-FU, MMC and CDDP can be an effective regimen for the treatment of acinar cell carcinoma of the pancreas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9949272     DOI: 10.1159/000018698

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  4 in total

1.  Acinar cell carcinoma of the pancreas.

Authors:  Rachel Pimenta Riechelmann; Paulo Marcelo Hoff; Renato Alonso Moron; Luiz Heraldo da Câmera Lopes; Antonio Carlos Buzaid
Journal:  Int J Gastrointest Cancer       Date:  2003

2.  Optimizing Chemotherapy of Pancreatic Acinar Cell Carcinoma: Our Experiences and Pooled Analysis of Literature.

Authors:  Jian-Ying Xu; Wen-Long Guan; Shi-Xun Lu; Xiao-Li Wei; Wen-Jie Shi; Chao Ren; Yu-Hong Li; Sheng-Ping Li; Miao-Zhen Qiu; Feng-Hua Wang
Journal:  Clin Med Insights Oncol       Date:  2022-04-30

3.  Acinar cell carcinoma of the pancreas with and without endocrine differentiation.

Authors:  I T Virlos; I M Papazachariou; R C N Wiliamson
Journal:  HPB (Oxford)       Date:  2002       Impact factor: 3.647

4.  Curative resection of a primarily unresectable acinar cell carcinoma of the pancreas after chemotherapy.

Authors:  Marius Distler; Felix Rückert; Dag D Dittert; Christian Stroszczynski; Frank Dobrowolski; Stephan Kersting; Robert Grützmann
Journal:  World J Surg Oncol       Date:  2009-02-25       Impact factor: 2.754

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.